Logo image of PIII

P3 HEALTH PARTNERS INC (PIII) Stock Fundamental Analysis

NASDAQ:PIII - Nasdaq - US7444131053 - Common Stock - Currency: USD

0.1866  0 (-1.32%)

After market: 0.1861 0 (-0.27%)

Fundamental Rating

1

Taking everything into account, PIII scores 1 out of 10 in our fundamental rating. PIII was compared to 109 industry peers in the Health Care Providers & Services industry. PIII may be in some trouble as it scores bad on both profitability and health. PIII is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year PIII has reported negative net income.
In the past year PIII has reported a negative cash flow from operations.
In the past 5 years PIII always reported negative net income.
In the past 5 years PIII always reported negative operating cash flow.
PIII Yearly Net Income VS EBIT VS OCF VS FCFPIII Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 -50M -100M -150M -200M -250M

1.2 Ratios

The Return On Assets of PIII (-12.32%) is worse than 73.15% of its industry peers.
PIII has a worse Return On Equity (-85.21%) than 77.78% of its industry peers.
Industry RankSector Rank
ROA -12.32%
ROE -85.21%
ROIC N/A
ROA(3y)-14.71%
ROA(5y)-27.73%
ROE(3y)-1558.6%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
PIII Yearly ROA, ROE, ROICPIII Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 0 -1K -2K -3K -4K

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for PIII so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
PIII Yearly Profit, Operating, Gross MarginsPIII Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 0 -10 -20 -30 -40 -50

More info and screens

0

2. Health

2.1 Basic Checks

PIII does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, PIII has more shares outstanding
PIII has a worse debt/assets ratio than last year.
PIII Yearly Shares OutstandingPIII Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 20M 40M 60M 80M 100M
PIII Yearly Total Debt VS Total AssetsPIII Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 500M 1B 1.5B 2B

2.2 Solvency

Based on the Altman-Z score of -0.17, we must say that PIII is in the distress zone and has some risk of bankruptcy.
PIII's Altman-Z score of -0.17 is on the low side compared to the rest of the industry. PIII is outperformed by 75.93% of its industry peers.
A Debt/Equity ratio of 1.11 is on the high side and indicates that PIII has dependencies on debt financing.
PIII has a Debt to Equity ratio of 1.11. This is in the lower half of the industry: PIII underperforms 65.74% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.11
Debt/FCF N/A
Altman-Z -0.17
ROIC/WACCN/A
WACC7.49%
PIII Yearly LT Debt VS Equity VS FCFPIII Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 0 100M -100M 200M

2.3 Liquidity

A Current Ratio of 0.53 indicates that PIII may have some problems paying its short term obligations.
PIII has a worse Current ratio (0.53) than 89.81% of its industry peers.
A Quick Ratio of 0.53 indicates that PIII may have some problems paying its short term obligations.
PIII has a Quick ratio of 0.53. This is amonst the worse of the industry: PIII underperforms 87.04% of its industry peers.
Industry RankSector Rank
Current Ratio 0.53
Quick Ratio 0.53
PIII Yearly Current Assets VS Current LiabilitesPIII Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 50M 100M 150M 200M 250M

More info and screens

6

3. Growth

3.1 Past

PIII shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 71.75%, which is quite impressive.
PIII shows a strong growth in Revenue. In the last year, the Revenue has grown by 25.37%.
The Revenue has been growing by 70.57% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)71.75%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-141.67%
Revenue 1Y (TTM)25.37%
Revenue growth 3Y37.65%
Revenue growth 5Y70.57%
Sales Q2Q%25.58%

3.2 Future

The Earnings Per Share is expected to grow by 10.27% on average over the next years. This is quite good.
Based on estimates for the next years, PIII will show a quite strong growth in Revenue. The Revenue will grow by 10.95% on average per year.
EPS Next Y-1.61%
EPS Next 2Y17.65%
EPS Next 3Y10.27%
EPS Next 5YN/A
Revenue Next Year23.34%
Revenue Next 2Y10.41%
Revenue Next 3Y10.95%
Revenue Next 5YN/A

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
PIII Yearly Revenue VS EstimatesPIII Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 500M 1B 1.5B
PIII Yearly EPS VS EstimatesPIII Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 -1 -2 -3 -4 -5

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for PIII. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for PIII. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
PIII Price Earnings VS Forward Price EarningsPIII Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60 80

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
PIII Per share dataPIII EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 2 3 4

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y17.65%
EPS Next 3Y10.27%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for PIII!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

P3 HEALTH PARTNERS INC

NASDAQ:PIII (2/5/2025, 8:20:49 PM)

After market: 0.1861 0 (-0.27%)

0.1866

0 (-1.32%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)11-12 2024-11-12/amc
Earnings (Next)N/A N/A
Inst Owners23.63%
Inst Owner Change2.65%
Ins Owners3.18%
Ins Owner Change0%
Market Cap66.96M
Analysts80
Price Target0.77 (312.65%)
Short Float %3.47%
Short Ratio1.76
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-367.32%
Min EPS beat(2)-658.17%
Max EPS beat(2)-76.47%
EPS beat(4)0
Avg EPS beat(4)-219.44%
Min EPS beat(4)-658.17%
Max EPS beat(4)-47.05%
EPS beat(8)3
Avg EPS beat(8)-109.32%
EPS beat(12)5
Avg EPS beat(12)-79.65%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-2.83%
Min Revenue beat(2)-3.06%
Max Revenue beat(2)-2.59%
Revenue beat(4)2
Avg Revenue beat(4)3.66%
Min Revenue beat(4)-3.06%
Max Revenue beat(4)12.24%
Revenue beat(8)5
Avg Revenue beat(8)2.74%
Revenue beat(12)7
Avg Revenue beat(12)5.11%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-69.59%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-312.45%
EPS NY rev (1m)0%
EPS NY rev (3m)-125.22%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-3.4%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.09%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.05
P/FCF N/A
P/OCF N/A
P/B 0.56
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.76
EYN/A
EPS(NY)-0.4
Fwd EYN/A
FCF(TTM)-0.19
FCFYN/A
OCF(TTM)-0.19
OCFYN/A
SpS4.12
BVpS0.34
TBVpS-1.32
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -12.32%
ROE -85.21%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-14.71%
ROA(5y)-27.73%
ROE(3y)-1558.6%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover1.77
Health
Industry RankSector Rank
Debt/Equity 1.11
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 0.25%
Cap/Sales 0.01%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.53
Quick Ratio 0.53
Altman-Z -0.17
F-Score3
WACC7.49%
ROIC/WACCN/A
Cap/Depr(3y)14.57%
Cap/Depr(5y)154.5%
Cap/Sales(3y)0.3%
Cap/Sales(5y)0.5%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)71.75%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-141.67%
EPS Next Y-1.61%
EPS Next 2Y17.65%
EPS Next 3Y10.27%
EPS Next 5YN/A
Revenue 1Y (TTM)25.37%
Revenue growth 3Y37.65%
Revenue growth 5Y70.57%
Sales Q2Q%25.58%
Revenue Next Year23.34%
Revenue Next 2Y10.41%
Revenue Next 3Y10.95%
Revenue Next 5YN/A
EBIT growth 1Y-39.53%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year1.72%
EBIT Next 3Y30.82%
EBIT Next 5YN/A
FCF growth 1Y44.45%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y43.03%
OCF growth 3YN/A
OCF growth 5YN/A